Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $82.26 | 2 | 73.8% |
| Education | $29.26 | 2 | 26.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $82.26 | 2 | $0 (2019) |
| PFIZER INC. | $29.26 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $70.43 | 3 | Astellas Pharma US Inc ($41.17) |
| 2017 | $41.09 | 1 | Astellas Pharma US Inc ($41.09) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/27/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2019 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $41.17 | General |
| 01/03/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $41.09 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,049 | 1,415 | $313,405 | $90,740 |
| 2022 | 12 | 1,148 | 1,556 | $267,934 | $88,178 |
| 2021 | 14 | 1,409 | 1,937 | $307,667 | $105,319 |
| 2020 | 18 | 2,468 | 3,828 | $548,638 | $188,126 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 37 | 46 | $7,590 | $4,861 | 64.0% |
| 81002 | Urinalysis, manual test | Office | 2020 | 873 | 1,407 | $21,105 | $4,808 | 22.8% |
| 55700 | Biopsy of prostate gland | Office | 2020 | 25 | 25 | $8,525 | $4,506 | 52.9% |
| 52224 | Destruction of (less than 0.5 centimeters) growths of the bladder and bladder canal (urethra) using an endoscope | Facility | 2020 | 15 | 22 | $30,074 | $3,320 | 11.0% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2020 | 23 | 31 | $26,350 | $3,249 | 12.3% |
| 52310 | Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | Office | 2020 | 16 | 16 | $10,352 | $3,144 | 30.4% |
| 76872 | Ultrasound of rectum | Office | 2020 | 25 | 25 | $5,500 | $2,651 | 48.2% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2020 | 25 | 25 | $6,500 | $1,079 | 16.6% |
| 51702 | Insertion of indwelling bladder catheter | Office | 2020 | 12 | 25 | $3,125 | $1,031 | 33.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 22 | 22 | $2,090 | $831.18 | 39.8% |
About Dr. Izzuddin Mansur, M.D
Dr. Izzuddin Mansur, M.D is a Urology healthcare provider based in Crossville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508828344.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Izzuddin Mansur, M.D has received a total of $111.52 in payments from pharmaceutical and medical device companies, with $70.43 received in 2019. These payments were reported across 4 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($82.26).
As a Medicare-enrolled provider, Mansur has provided services to 6,074 Medicare beneficiaries, totaling 8,736 services with total Medicare billing of $472,363. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Crossville, TN
- Active Since 04/05/2006
- Last Updated 06/14/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508828344
Products in Payments
- Xtandi (Drug) $41.09
- XTANDI (Drug) $29.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.